Propanil

Propanil

SCHEMBL634840

CCC(=O)Nc1ccc(Cl)c(Cl)c1.[Ag]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.96
TSHR P16473 1/20 0.71
ALDH1A1 P00352 3/20 0.61
KMT2A Q03164 3/20 0.61
MEN1 O00255 2/20 0.61
EPHX1 P07099 1/20 0.61
EPHX2 P34913 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.59
HDAC3 O15379 1/20 0.58
HDAC4 P56524 1/20 0.58
HDAC1 Q13547 1/20 0.58
HDAC7 Q8WUI4 1/20 0.58
HDAC2 Q92769 1/20 0.58
HDAC10 Q969S8 1/20 0.58
HDAC11 Q96DB2 1/20 0.58
HDAC8 Q9BY41 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
HDAC9 Q9UKV0 1/20 0.58
HDAC5 Q9UQL6 1/20 0.58
ESRRA P11474 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propanil SCHEMBL1702271 0.98 CYP3A4 (1.00) CYP3A4TSHRALDH1A1KMT2AMEN1
Propanil SCHEMBL21900164 0.98 CYP3A4 (1.00) CYP3A4TSHRALDH1A1KMT2AMEN1
Propanil SCHEMBL26871 0.98 CYP3A4 (1.00) CYP3A4TSHRALDH1A1KMT2AMEN1
Propanil SCHEMBL8983219 0.96 CYP3A4 (0.96) CYP3A4TSHRALDH1A1KMT2AMEN1
Propanil SCHEMBL19358624 0.89 CYP3A4 (0.82) CYP3A4TSHRALDH1A1KMT2AMEN1
SCHEMBL11865051 0.85 CYP3A4 (0.75) CYP3A4TSHRALDH1A1KMT2AMEN1
SCHEMBL14426539 0.84 CYP3A4 (0.75) CYP3A4TSHRALDH1A1KMT2AMEN1
SCHEMBL3674141 0.84 CYP3A4 (0.75) CYP3A4ALDH1A1KMT2AMEN1EPHX1
SCHEMBL12796807 0.84 CYP3A4 (0.75) CYP3A4TSHRALDH1A1KMT2AMEN1
SCHEMBL15302068 0.83 TSHR (1.00) CYP3A4TSHRALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2419446-A2 HUMANIZED ANTIBODY COMPOSITIONS AND METHODS FOR BINDING LYSOPHOSPHATIDIC ACID Lpath, Inc. (US) 2012-02-22 EP disclosed
WO-2010121093-A2 HUMANIZED ANTIBODY COMPOSITIONS AND METHODS FOR BINDING LYSOPHOSPHATIDIC ACID LPATH, INC. (US) 2010-10-21 WO disclosed
WO-2010036945-A2 NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-04-01 WO disclosed
WO-2008147900-A2 GENE EXPRESSION MARKERS FOR INFLAMMATORY BOWEL DISEASE GENENTECH, INC. (US) 2008-12-04 WO disclosed
EP-1824886-A2 FULLY HUMAN MONOCLONAL ANTIBODIES TO IL-13 Amgen Fremont Inc. (US) 2007-08-29 EP disclosed
WO-2006055638-A2 FULLY HUMAN MONOCLONAL ANTIBODIES TO IL-13 ABGENIX, INC. (US) 2006-05-26 WO disclosed
EP-1145011-A3 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR Genentech, Inc. (US) 2002-09-11 EP disclosed
EP-1216056-A1 BLOCKING IMMUNE RESPONSE TO A FOREIGN ANTIGEN USING AN ANTAGONIST WHICH BINDS TO CD20 Genentech Inc. (US) 2002-06-26 EP disclosed
EP-1198568-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES Genentech, Inc. (US) 2002-04-24 EP disclosed
EP-1196186-A2 PROMOTION OR INHIBITION OF ANGIOGENESIS AND CARDIOVASCULARIZATION BY TUMOR NECROSIS FACTOR LIGAND/RECEPTOR HOMOLOGS Genentech, Inc. (US) 2002-04-17 EP disclosed
WO-2000075327-A1 METHODS AND COMPOSITIONS FOR INHIBITING NEOPLASTIC CELL GROWTH GENENTECH, INC. (US) 2000-12-14 WO disclosed
WO-2000073452-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES GENENTECH, INC. (US) 2000-12-07 WO disclosed
WO-2000070050-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES GENENTECH, INC. (US) 2000-11-23 WO disclosed
WO-2000067796-A1 TREATMENT OF AUTOIMMUNE DISEASES WITH ANTAGONISTS WHICH BIND TO B CELL SURFACE MARKERS GENENTECH, INC. (US) 2000-11-16 WO disclosed
WO-2000043790-A2 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR GENENTECH, INC. (US) 2000-07-27 WO disclosed
WO-1999052938-A2 IDENTIFICATION OF CHEMICAL ACTIVE AGENTS FOR INHIBITING THE 1-DESOXY-D-XYLULOSE-5-PHOSPHATE BIOSYNTHETIC PATHWAY IN PARASITES JOMAA HASSAN (DE) 1999-10-21 WO disclosed
WO-1998021334-A9 ANTIBODY MG1 RECOGNIZING A SMALL SUBSET OF HUMAN HEMATOPOIETIC CELLS 1998-10-01 WO disclosed
EP-0863986-A1 TRANSFERRIN BINDING PROTEINS OF PASTEURELLA HAEMOLYTICA AND VACC INES CONTAINING SAME Lo, Reggie Y. C. (CA) 1998-09-16 EP disclosed
WO-1998021334-A2 ANTIBODY MG1 RECOGNIZING A SMALL SUBSET OF HUMAN HEMATOPOIETIC CELLS MORPHOGENESIS, INC. (US) 1998-05-22 WO disclosed
WO-1997020934-A1 TRANSFERRIN BINDING PROTEINS OF PASTEURELLA HAEMOLYTICA AND VACC INES CONTAINING SAME LO REGGIE Y C (CA) 1997-06-12 WO disclosed